Desmoid tumor of the tongue

Desmoid tumors are rare neoplasms accounting for 0.03% of all neoplasms and have an estimated incidence of 2 to 4 per million per year. World Health Organization currently refers to all of the deep types of fibromatosis as desmoidtype of fibromatoses. The term ?desmoid? refers to the hard, tendon-like appearance of the tumor. The etiological factors suggested include genetic, endocrine and physical factors. About fifty percent of desmoid tumors arise in the abdominal region. The extra-abdominal desmoid tumors present a difficult problem in recognition and management especially because of the striking discrepancy between its deceptively harmless microscopic appearance and its potential to attain a large size, to recur, and to infiltrate neighboring tissues in the manner of a fibrosarcoma. Desmoid tumors are very rare in the oral cavity with less than 5% of cases constituting oral soft tissue fibromatosis. A 22-year old mentally retarded female patient with desmoid tumor occurring in the tongue is presented here

A Reconfigurable Broadcast Scan Compression Scheme Using Relaxation Based Test Vector Decomposition

In this paper, we propose an effective reconfigurable broadcast scan compression scheme that employs partitioning and relaxation-based test vector decomposition. Given a constraint on the number of tester channels, the technique classifies the test set into acceptable and bottleneck vectors. Bottleneck vectors are then decomposed into a set of vectors that meet the given constraint. The acceptable and decomposed test vectors are partitioned into the smallest number of partitions while satisfying the tester channels constraint to reduce the decompressor area. Thus, the technique by construction satisfies a given tester channels constraint at the expense of increased test vector count and number of partitions, offering a tradeoff between test compression, test application time and test decompression circuitry area. Experimental results demonstrate that the proposed technique achieves better compression ratio in comparison to other test compression techniques

A Reconfigurable Broadcast Scan Compression Scheme Using Relaxation Based Test Vector Decomposition

In this paper, we propose an effective reconfigurable broadcast scan compression scheme that employs partitioning and relaxation-based test vector decomposition. Given a constraint on the number of tester channels, the technique classifies the test set into acceptable and bottleneck vectors. Bottleneck vectors are then decomposed into a set of vectors that meet the given constraint. The acceptable and decomposed test vectors are partitioned into the smallest number of partitions while satisfying the tester channels constraint to reduce the decompressor area. Thus, the technique by construction satisfies a given tester channels constraint at the expense of increased test vector count and number of partitions, offering a tradeoff between test compression, test application time and test decompression circuitry area. Experimental results demonstrate that the proposed technique achieves better compression ratio in comparison to other test compression techniques

Metaplastic breast carcinoma: Clinicopathological parameters and prognostic profile

Introduction: Metaplastic breast carcinoma (MBC) is defined as breast cancer with a heterologous non-glandular component. MBC is considered a special type of breast cancer with a prognosis that is worse than invasive ductal carcinoma (IDC) of the breast. MBC is the most common breast cancer with a triple-negative profile. Therefore, in this study, we evaluated the clinicopathological parameters, recurrence and survival of MBC in our population.Methods: We conducted a retrospective observational study in the Department of Histopathology at Prince Faisal Oncology Centre, Buraidah, Saudi Arabia, over a period of five years. All cases diagnosed as MBC were included in the study. Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) immunohistochemistry (IHC) was performed on representative tissue blocks.Results: Total 183 cases of MBCs were included in the study, out of which 120 cases were excision specimens. The mean age of the patients was 48.84±12.99 years, and the most common age group was between 36 and 50 years of age. Most of the cases were tumor (T) stage T3 (50%), and nodal metastasis was present in 40% of cases. Most cases were grade III (78.7%). ER, PR and HER2/neu positivity was noted in 15.8%, 13.1%, and 9.8% cases, respectively. Follow-up data were available for 70 cases, with a median follow-up period of 4 (1-7) years. Tumor recurrence was noted in 31.4% cases, with a survival rate of 71.4%. Squamous, chondroid, spindle cell differentiation, and matrix production were noted in 70.5%, 7.1%, 13.7%, and 2.2% cases, respectively. A significant association of squamous differentiation was noted with HER2/neu positivity. An inverse association of spindle cell differentiation was seen with axillary metastasis. Survival analysis by Kaplan-Meier revealed a significant association of survival with tumor recurrence.Conclusion: MBC is an important subtype of breast cancer, histopathological identification of which is challenging, owing to varied histological differentiation. We found squamous differentiation to be the most common in MBC, which was associated with HER2/neu positivity. A high recurrence rate of MBC was also observed in our study that was significantly associated with survival

A Bibliometric Review of Research Trends on Kenaf Fiber Reinforced Concrete

To prevent the excessive depletion of natural resources, sustainable development requires using alternate sustainable materials. Researchers in the field of advanced construction materials are increasingly paying attention to kenaf fibers as a "green" material because of their possible application in composites to advance sustainable development. However, there has been no attempt of scientometric analysis to investigate the comprehensive understanding of the present state of applications of kenaf fibers in reinforced concrete. The study aims to perform a bibliometric analysis of the existing kenaf fibers reinforced concrete literature and to provide a picture of the research status during the last ten years from 2013 to September 2022. There were 303 articles extracted from the Scopus database. The “VOSviewer” tool was employed to visualize the literature containing the most active scientific journals, countries, and highly used keywords in the field of fibers reinforced concrete. The outcomes showed that “Hybrid Composites”, “Impact Strength”, “Water Absorption”, “Scanning Electron Microscopy”, “Polypropylenes” and “Polymer Composite” have recently emerged as themes related to the applications of KFRC, and grabbed the interest of academics, may also offer future research opportunities. Additionally, according to the frequency of the keywords used, three important research domains associated with kenaf fibers within the concrete in the construction materials field have been identified, including “Mechanical Properties”, “Fiber Reinforced Plastics”, and “Tensile Strength”. Furthermore, the recent studies on the impact of kenaf fiber utilization on the structural performance of reinforced concrete are reviewed. Accordingly, the explanations related to research findings, suggestions for future studies have been provided on the incorporation of kenaf fibers reinforced concrete in civil engineering applications

A comprehensive assessment of laser welding of biomedical devices and implant materials: recent research, development and applications

This review comprehensively covers the research accomplished in the field of laser welding of biomedical devices and implant materials. Laser welding technology in the recent past has been envisaged for numerous biomedical applications encompassing the reconstruction, fabrication, joining and sealing of the implanted biomaterials. It is the most studied and an increasingly applied manufacturing technology that garners the distinct advantages of smaller beam diameters leading to minimal thermal cycles that reduce the size of heat affected zone and instigate microstructural refinement. This paper presents a detailed critical review of similar and dissimilar welding of titanium alloys, cobalt-chromium alloys, steel, bulk metallic glasses and polymer-based biomaterials. Mechanical properties of the welded joints such as fatigue load, tensile and flexural strength, elongation, hardness and modulus of elasticity are discussed. The effect of laser processing parameters on microstructural features and the corresponding metallurgical defects encountered such as cracks, porosities, voids or the loss of alloying elements are reviewed. Furthermore, the corrosion behavior, cytotoxicity and biocompatibility of the welded implants in the simulated mediums are discussed. Furthermore, this article also summarizes the present-day applications associated with implant materials and is aimed at the further involvement of the laser precision technology in producing materials and joints with desired biomechanical characteristics. Lastly, the current research gaps on the role of laser welding of implants and the anticipated emerging fronts are summarized

Molecular and clinical analysis of Ellis-van Creveld syndrome in the United Arab Emirates

<p>Abstract</p> <p>Background</p> <p>Ellis-van Creveld (EvC) syndrome is an autosomal recessive chondrodysplastic condition with clinical manifestations that include short-limbs and ribs, postaxial polydactyly and dysplastic nails and teeth. In about two thirds of patients, mutations in either <it>EVC </it>or <it>EVC2 </it>genes have been found to be the underlying cause.</p> <p>Methods</p> <p>In this paper, we describe the molecular (DNA sequencing) and clinical analysis of six children diagnosed with EvC from four different families from the United Arab Emirates (UAE).</p> <p>Results</p> <p>All the children had the common clinical and radiological features of this syndrome. However, DNA sequence analysis of the genes shown to be involved (<it>EVC </it>and <it>EVC2</it>) revealed a novel splice site mutation (c.2047-1G>T) in intron 13 of <it>EVC2 </it>gene in one family. In addition, we confirm previous mutational analyses that showed a truncating mutation in exon 13 of <it>EVC </it>gene (c.1813C>T; p.Q605X) in the second family and a single nucleotide deletion (c.981delG; p.K327<it>fs</it>) in exon 8 of <it>EVC2 </it>gene in the third family. No mutations in the exons, splice sites or the promoter regions of either gene have been found in the index case of the fourth family who exhibited "EvC-like" features.</p> <p>Conclusions</p> <p>Given the small population size of UAE, our data illustrates further the molecular heterogeneity observed in EvC patients and excludes the possibility of a common founder effect for this condition in the UAE reflecting the current ethnic diversity of the country.</p

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods: Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15–39 years to define adolescents and young adults. Findings: There were 1·19 million (95% UI 1·11–1·28) incident cancer cases and 396 000 (370 000–425 000) deaths due to cancer among people aged 15–39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5–65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8–57·9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9–15·6] per 100 000 person-years) and middle SDI (13·6 [12·6–14·8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9–25·2) DALYs to the global burden of disease, of which 2·7% (1·9–3·6) came from YLDs and 97·3% (96·4–98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation: Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Funding: Bill &amp; Melinda Gates Foundation, American Lebanese Syrian Associated Charities, St Baldrick's Foundation, and the National Cancer Institute

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe